HBM Partners is a Swiss healthcare investor with USD 2.1 billion assets under management.
Founded in 2001, HBM Partners focuses on venture, growth and buy-out financings of private companies as well as on investments in public companies in the biopharma, medtech, diagnostics and healthcare sectors in Europe and North America as well as in India, China and other Emerging Markets.
Regulated by FINMA, HBM Partners advises SIX-listed HBM Healthcare Investments Ltd and several specialised public and private equity investment funds. HBM Partners features a track-record of over 100 investments that resulted in more than 60 trade sales and IPOs with significant value creation. HBM Partners is a trusted source of capital for entrepreneurial biopharma and healthcare companies. Investments usually range between USD 5 to 50 million.
HBM Partners’ team of experienced professionals will source, analyse and engage in private and public healthcare investments and support the growth of the portfolio companies through all stages of development, focusing on adding value by leveraging its experience and world-wide industry network.
